CA-Pharma s.r.o.

Active
IČO 46328203limited liability company (s.r.o.)Founded 2011Čadca

Key figures

1 039 116 €+397,1%
Revenue 2025
+132,4%
Average annual growth 2020–2025
0500 k1 m1,5 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

No dividends were distributed.

Equity decreased by 17 034 € other than from retained earnings — e.g. a share capital reduction, a payout from other funds or a revaluation. The open data does not show whether this was a payout to shareholders.

History
dividends other decrease in equity
20250 €+17 034 € other
20240 €
20230 €
20220 €
20210 €

Summary: CA-Pharma s.r.o.

What kind of company is it?

CA-Pharma s.r.o. (IČO 46328203) is a limited liability company (s.r.o.). The company was incorporated in 2011 and has existed for 15 years. Registered office according to the register: Čadca. Main activity according to the Statistical Office: ostatný nešpecializovaný maloobchod (SK NACE 4712). Size category by number of employees: 3–4 employees.

Who runs the company and who owns it?

The statutory body has 2 members. According to the register, the company has 2 shareholders. The registered capital is 5 100 €.

How is the company doing financially?

Revenue for 2025 was 1 039 116 €, up 397 % on the previous year (209 031 €). From 2020 to 2025, revenue grew by an average of 132 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 48 720 € (4,7 % of revenue). The company was profitable in 1 of the 6 reported years. Personnel costs for 2025 were 40 978 €. At the end of 2025 the company had total assets of 239 437 € and equity of 49 763 € (equity ratio 20,8 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 18. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)000209 0311 039 116
Profit for the reporting year000-56 28048 720
Retained earnings of previous periods-23 223-23 223-22 6240-56 600
Total assets359359245139 542239 437
Total liabilities18 46218 46217 749121 145189 674
Total equity-18 103-18 103-17 50418 39749 763
Calculated dividends00000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Documents in the Register of Financial Statements15

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 4712)
CA-Pharma s.r.o. (IČO 46328203) – revenue 1M € | icoprofil.sk